These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8591714)

  • 1. Metabolic regulation and microangiopathy in a cohort of Japanese IDDM-patients.
    Yokoyama H; Uchigata Y; Otani T; Saeki A; Aoki K; Kasahara T; Omori Y; Borch-Johnsen K
    Diabetes Res Clin Pract; 1995 Sep; 29(3):203-9. PubMed ID: 8591714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of proliferative retinopathy in Japanese patients with IDDM: Tokyo Women's Medical College Epidemiologic Study.
    Yokoyama H; Uchigata Y; Otani T; Aoki K; Maruyama A; Maruyama H; Hori S; Matsuura N; Omori Y
    Diabetes Res Clin Pract; 1994 Jun; 24(2):113-9. PubMed ID: 7956708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of early-onset proliferative retinopathy in IDDM is closely related to cardiovascular autonomic neuropathy.
    Krolewski AS; Barzilay J; Warram JH; Martin BC; Pfeifer M; Rand LI
    Diabetes; 1992 Apr; 41(4):430-7. PubMed ID: 1607070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early increase in HbA1c trajectory predicts development of severe microangiopathy in patients with type 1 diabetes: the VISS study.
    Arnqvist HJ; Ludvigsson J; Nordwall M
    BMJ Open Diabetes Res Care; 2024 May; 12(3):. PubMed ID: 38719508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term mortality and retinopathy in type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2010 May; 88 Thesis1():1-14. PubMed ID: 20500731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of diabetic nephropathy in Japanese patients with insulin-dependent diabetes mellitus: Tokyo Women's Medical College epidemiologic study.
    Yokoyama H; Uchigata Y; Otani T; Maruyama A; Yano-Aoki K; Kanematsu S; Kasahara T; Matsuura N; Omori Y
    J Diabetes Complications; 1994; 8(1):7-12. PubMed ID: 8167391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of and risk factors for proliferative retinopathy and its association with blindness among diabetes clinic attenders.
    Janghorbani M; Jones RB; Allison SP
    Ophthalmic Epidemiol; 2000 Dec; 7(4):225-41. PubMed ID: 11262670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The appearance of retinopathy and progression to proliferative retinopathy: the WHO Multinational Study of Vascular Disease in Diabetes.
    Keen H; Lee ET; Russell D; Miki E; Bennett PH; Lu M
    Diabetologia; 2001 Sep; 44 Suppl 2():S22-30. PubMed ID: 11587046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications and prognosis of children with IDDM.
    Tajima N; Matsushima M
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S165-70. PubMed ID: 7859601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
    Klein R; Moss S
    Arch Intern Med; 1995 Apr; 155(7):745-54. PubMed ID: 7695463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low cumulative incidence of proliferative retinopathy in childhood-onset type 1 diabetes: a 24-year follow-up study.
    Skrivarhaug T; Fosmark DS; Stene LC; Bangstad HJ; Sandvik L; Hanssen KF; Joner G
    Diabetologia; 2006 Oct; 49(10):2281-90. PubMed ID: 16955208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for prevalent diabetic retinopathy and proliferative diabetic retinopathy in type 1 diabetes.
    Laiginhas R; Madeira C; Lopes M; Neves JS; Barbosa M; Rosas V; Carvalho D; Falcão-Reis F; Falcão M
    Endocrine; 2019 Nov; 66(2):201-209. PubMed ID: 31407162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic diabetic complications in patients with MODY3 diabetes.
    Isomaa B; Henricsson M; Lehto M; Forsblom C; Karanko S; Sarelin L; Häggblom M; Groop L
    Diabetologia; 1998 Apr; 41(4):467-73. PubMed ID: 9562352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of microvascular complications in type 1 diabetic patients at onset: the role of metabolic memory.
    Giordano C; Amato MC; Ciresi A; Citarrella R; Mantione L; Accidenti M; Pantò F; Guarnotta V; Allotta ML; Criscimanna A; Galluzzo A
    Eur J Intern Med; 2011 Jun; 22(3):266-74. PubMed ID: 21570646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for importance of gender and birth cohort for risk of IDDM in offspring of IDDM parents.
    Tuomilehto J; Podar T; Tuomilehto-Wolf E; Virtala E
    Diabetologia; 1995 Aug; 38(8):975-82. PubMed ID: 7589885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy.
    Tarnow L; Cambien F; Rossing P; Nielsen FS; Hansen BV; Ricard S; Poirer O; Parving HH
    Nephrol Dial Transplant; 1996 Jun; 11(6):1019-23. PubMed ID: 8671962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood.
    Olsen BS; Johannesen J; Sjølie AK; Borch-Johnsen K; Hougarrdss P; Thorsteinsson B; Prammingss S; Marinelli K; Mortensen HB
    Diabet Med; 1999 Jan; 16(1):79-85. PubMed ID: 10229298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic factors in the development of retinopathy of juvenile-onset type I diabetes mellitus.
    Khosla PK; Sharma K; Tewari HK; Bajaj JS; Vaidya MC
    Indian J Ophthalmol; 1994 Mar; 42(1):23-5. PubMed ID: 7927626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications.
    Yosipovitch G; Hodak E; Vardi P; Shraga I; Karp M; Sprecher E; David M
    Diabetes Care; 1998 Apr; 21(4):506-9. PubMed ID: 9571332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fulminant type 1 diabetes as a high risk group for diabetic microangiopathy--a nationwide 5-year-study in Japan.
    Murase Y; Imagawa A; Hanafusa T; Iwahashi H; Uchigata Y; Kanatsuka A; Kawasaki E; Kobayashi T; Shimada A; Shimizu I; Maruyama T; Makino H
    Diabetologia; 2007 Mar; 50(3):531-7. PubMed ID: 17235525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.